Preferred regimens based on AASLD treatment guidelines
| CLASS | BRAND NAME | GENERIC/COMMON NAME | PREFERRED | MANUFACTURER |
|---|---|---|---|---|
|
Nucleoside reverse transcriptase inhibitor (NRTI) |
Epivir-HBV | lamivudine (3TC) | 8 | GlaxoSmithKline |
|
Nucleoside reverse transcriptase inhibitor (NRTI) |
Hepsera | adefovir (ADV) | 8 | Gilead Sciences |
|
Nucleoside reverse transcriptase inhibitor (NRTI) |
Baraclude | entecavir (ETV) | 4 | Bristol-Myers Squibb |
|
Nucleoside reverse transcriptase inhibitor (NRTI) |
Vemlidy | tenofovir alafenamide (TAF) | 4 | Gilead Sciences |
|
Nucleoside reverse transcriptase inhibitor (NRTI) |
Viread | Genentech | 4 | Gilead Sciences |
| Interferon-alfa | Pegasys | peginterferon alfa-2a |
4 (in adults) |
Genentech |